Is CONSORT a Risk of Bias Tool for Experimental Studies: A Big Misunderstanding

February 2025 in “ Journal of Caring Sciences ”

Ehsan Sarbazi, Homayoun Sadeghi‐Bazargani

Studysummary This article emphasizes that the CONSORT statement is a guideline for reporting randomized controlled trials, not a tool for assessing risk of bias.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

Read the full study on jcs.tbzmed.ac.ir →

PubMed
DOI

Discuss this study in the Community →

Similar research 5

Collider Bias Undermines Our Understanding of COVID-19 Disease Risk and Severity 2020
Empirical Evidence of Observer Bias in Randomized Clinical Trials: Updated and Expanded Analysis of Trials With Both Blinded and Non-Blinded Outcome Assessors Journal of Clinical Epidemiology · 2025
Collider Bias Undermines Our Understanding of COVID-19 Disease Risk and Severity Nature Communications · 2020
Discrepancies in Safety Reporting for Chronic Back Pain Clinical Trials: An Observational Study from ClinicalTrials.gov and Publications BMC Medical Research Methodology · 2025
A Proposal for a New Design: The Exposure–Crossover Design Journal of Clinical Epidemiology · 2013

Related Community Posts Join

6 / 1000+ results

community PP405 2a study was a safety study. Some rational explaining.

22 upvotes 1 year ago

The conversation discusses the safety study of PP405, emphasizing that early trials focus on safety rather than efficacy, and that any efficacy data from such a short study should be viewed skeptically. It also highlights that the information released is primarily for securing funding, and that meaningful efficacy results are expected in later phases.

community Thinking about signing up for the setipiprant clinical trials

5 upvotes 9 years ago

The conversation discusses hair loss treatments, with the original poster considering joining a clinical trial for setipiprant after experiencing side effects from finasteride and disinterest in minoxidil. Some users express skepticism about setipiprant's effectiveness, while others encourage participation in the trial for potential benefits.

community The new Veritasium video made me conscious about a possible loss of effectiveness of DHT Inhibitors or Minoxidil

in Research/Science 18 upvotes 4 months ago

Concerns about the effectiveness of DHT inhibitors like finasteride and minoxidil due to potential polymorph issues. Experts suggest these concerns are largely unfounded, especially compared to rare cases like ritonavir.

community Haunting study is making me considering cycling fin/dut

in Research/Science 158 upvotes 1 year ago

Concerns about the long-term effects of dutasteride and finasteride on fertility, with discussions on cycling these medications to mitigate risks. The conversation highlights skepticism about study methodologies and the importance of weighing treatment risks against potential fertility issues.

community ABS-201 Trial - What should I know going in

in Research/Science 28 upvotes 6 months ago

The conversation is about a user preparing to join the ABS-201 clinical trial for hair loss treatment, which involves a prolactin inhibitor. The user plans to update others on their progress if enrolled.

community Joining clinical study for Clascoterone (Breezula)

in Research/Science 7 upvotes 1 year ago

The conversation is about a user considering joining a clinical study for Clascoterone (Breezula) after experiencing no results with topical finasteride and minoxidil, and side effects from oral finasteride. The user is seeking advice on clinical study participation and experiences.